Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652036%3A_____%2F15%3A00464077" target="_blank" >RIV/86652036:_____/15:00464077 - isvavai.cz</a>
Alternative codes found
RIV/61388971:_____/15:00464077
Result on the web
<a href="http://dx.doi.org/10.1007/s13238-015-0194-9" target="_blank" >http://dx.doi.org/10.1007/s13238-015-0194-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s13238-015-0194-9" target="_blank" >10.1007/s13238-015-0194-9</a>
Alternative languages
Result language
angličtina
Original language name
Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)
Original language description
Prostate secretory protein 94 (PSP94), a dominant protein of human seminal plasma known also as β-microseminoprotein (MSMB), has recently been shown to decrease serum level expression during prostate cancer (PC) progression and indicated as a novel promising serum oncomarker with a predictive role in PC diagnosis. In this work we aimed to generate a novel class of protein binders targeted to human PSP94 that can serve as robust capture proteins for improved PC diagnostics. We used high-complex combinatorial library derived from an albumin-binding domain (ABD) scaffold of streptococcal protein G with a theoretical complexity up to 2 x 1014 protein variants and ribosome display to generate a plasmid library of selected variants. Individual clones were characterized by binding of ABD-derived proteins to recombinant PSP94 and sequentially compared and characterized. Collection of 35 ABD-derived protein binders of human PSP94 (called PAB binders), corresponding to 29 different sequence variants, was generated. PAB036, PAB046 and PAB050 were identified as the most promising binding candidates characterized in ELISA. Their stability was verified by thermal shift assay and the binding affinity to the recombinant PSP94 was estimated by microscale thermophoresis. These PAB variants bound to PSP94-expressing human LNCaP prostate carcinoma cells and this binding was dose-dependently inhibited by recombinant PSP94. Thus, we generated a unique collection of novel proteins binders of human PSP94 that can serve as a valuable tool for human PSP94 detection and, with a further modification, as high-affinity capture proteins for the development of biosensors for more complex PC diagnostics.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Protein & Cell
ISSN
1674-800X
e-ISSN
—
Volume of the periodical
6
Issue of the periodical within the volume
10
Country of publishing house
CN - CHINA
Number of pages
6
Pages from-to
774-779
UT code for WoS article
000362653100010
EID of the result in the Scopus database
—